{"id":"W4290830423","doi":"10.1136/jnnp-2022-abn2.6","title":"Tofersen in adults with SOD1-ALS: phase 3 VALOR trial and open-label extension results","year":2022,"lang":"en","type":"article","venue":"Journal of Neurology Neurosurgery & Psychiatry","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Placebo; SOD1; Medicine; Clinical endpoint; Clinical trial; Adverse effect; Internal medicine; Statistical significance; Quality of life (healthcare); Physical therapy; Amyotrophic lateral sclerosis; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001836035,0.001207109,0.001637466,0.0002686267,0.0003059574,0.0007633155,0.0005895501,0.001497296,0.004782021],"category_scores_gemma":[0.0009462436,0.0002333238,0.001781413,0.0001679029,0.0004143082,0.0006547209,0.0002887284,0.001562394,0.0006763155],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004321661,"about_ca_system_score_gemma":0.0006948367,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005462944,"about_ca_topic_score_gemma":0.00174558,"domain_scores_codex":[0.9996436,0.0001588079,0.00002748427,0.00004954931,0.00004270151,0.00007790065],"domain_scores_gemma":[0.9995756,0.00009204902,0.00009798707,0.00003089113,0.00005732545,0.000146183],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8665668,0.01213301,0.002451069,0.002331551,0.001619359,0.0003005465,0.0002282541,0.0009202355,0.0209181,0.0005616436,0.005115372,0.08685407],"study_design_scores_gemma":[0.7998638,0.1809779,0.009221967,0.0002058847,0.0006969742,0.0004292066,0.0000827504,0.0006148682,0.002255877,0.0004678839,0.005142291,0.00004047343],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9769019,0.01132315,0.0009946708,0.0008136948,0.0003505281,0.003068445,0.002986728,0.0002641378,0.003296803],"genre_scores_gemma":[0.974894,0.006865229,0.003008673,0.001605293,0.0003973739,0.003793029,0.004203944,0.00005353273,0.00517897],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004782021,"threshold_uncertainty_score":0.01599747,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05989350031786727,"score_gpt":0.3542885449561264,"score_spread":0.2943950446382591,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}